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Abstract
Metal complexes of malonie acid (metal Mn(II), Co(II), Ni(II), Cu(II), Zn(II), Ag(I)) were
prepared and only the Ag(I) complex inhibited the growth of Candida albicans. Malonate complexes
incorporating the chelating 1,10-phenanthroline (1,10-phen) ligand showed a range of activities: good
(Mn(II), Cu(lI), Ag(I)); moderate (Zn(II)); poor (Co(II), Ni(II)). Metal-free 1,10-phen and Ag(CH3CO2)
were also highly active. The metal-free non-chelating ligands 1,7- phenanthroline and 4,7-phenanthroline
were inactive and the Cu(II), Mn(II) and Zn(II) complexs of 1,7-phen displayed only marginal activity.
Whereas the Cu(II) malonate/1,10-phen complex induces significant cellular oxidative stress the Zn(II)
analogue does not.
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Introduction
1,10-Phenanthroline (1,10-phen), 2,2’-bipyridine (2,2’-bipy) (Fig. 1) and their substituted
derivatives, both in the metal-free state and as ligands coordinated to transition metals, disturb the
functioning of a wide variety of biological systems. When the metal-free N,N-chelating bases are
found to be bioactive it is usually assumed that the sequestering of trace metals is involved, and
that the resulting metal complexes are the actual active species.2’3
(a) (b)
Figure 1. (a) 1,10-Phenanthroline (1,10-phen); (b) 2,2’-bipyridine (2,2’-bipy)
4 Administering the metal-free bases is known to affect succinic oxidase,
triphosphopyridine nucleotide nitrate reductase, zymase
6 and the reduction of fumerate and malate
by molecular hydrogen in the presence of washed suspensions of Escherichia coli. The action of
liver and intestine phosphomonoesterases on [-glycerophosphate and of intestine pyrophosphotase
on pyrophosphate is also considerably accelerated by solutions of the bases.’9 Whilst 1,10-phen
2+ slows cysteine oxidation 2,2’-bipy and the Fe(II), complex [Fe(2,2-bipy)3] activate cathepsin
and also catalyse the autoxidation of linoleic acid.
’2 Whereas the oxygen uptake of green leaves
3
and the endogeneous respiration of anabaema
14 are inhibited by the bases, both 1,10-phen and 2,2’-
bipy accelerate the oxygen consumption of homogenised brain brei. Highly potent anthelmintic
action has been observed with both bases.
5 Furthermore, a solution of 10-phen suppresses the
chemotactic power of"guinea pig" leucocytes without destroying the cells.6’
The in vitro antibacterial action of 1,10-phen has been demonstrated on several species of
2O 3172 bacteria.’ Whereas phenanthroline metal complexes can be bacteriostatic and bacteriocidal
towards many Gram-positive bacteria they are relatively ineffective against Gram-negative
organisms. Similar reactivity trends against Gram-positive and Gram-negative bacteria were found
for Cu(II) and Fe(II/III) complexes of oxine.
2
Whereas m- and p-substituted phenanthrolines were less effective than 1,10-phen at
preventing fungal growth, 2,9-dimethyl-l,10-phenanthroline (dmphen) was the most potent
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inhibitor.
22 Recent in vitro studies have shown that although 2,2’-bipy and its metal complexes did
not suppress the growth of clinical isolates of Candida species dilute aqueous solutions of 10-
phen and its Cu(II) and Mn(II) complexes were extremely toxic to the cells.3’24
Metal complexes of phenanthroline and bipyridine are toxic to mice and rats
25 and to frogs
and rabbits26, and their action on enzymes 1’25’27 and on neuromuscular transmission
28 has been
2+ demonstrated. [Fe(2,2-blpy)3] is excreted unchanged through the kidneys of frogs and
rabbits,26’2932 and experiments using radiolabelled Ruhave revealed that [Ru(1,10-phen)3]
2+ is
25 unts were lethal when introduced not metabolised in rats and mice. Very small amo
intraperitoneally, intravenously or subcutaneously, but even large oral doses did not cause death.
Absorption through the ntestine was slow (this has also been observed on humans33) and, owing to
rapid elimination through the kidney, it was not possible to build up the lethal concentration in the
blood. The symptoms caused by the complexes, i.e., torpor, tremor, paralysis of the limbs, chronic
convulsions, an unaffected heart, and death due to respiratory failure, indicated an attack on the
central nervous system. These conclusions were supported by findings that the complexes are
potent inhibitors of acetylcholinesterase and that they have a curare-like action on neuromuscular
transmission. Normal activity was restored by washing out the complexes.
The in vitro antitumour activities of Cu(II) complexes of 3,5-disubstituted salicylates
increased by an order of magnitude by incorporation of a phenanthroline ligand into the complex.
34
These ternary complexes had cytotoxicities comparable to that of the anticancer drug cisplatin, cis-
[PtCI(NH3)2]. However, although [Cu(dmphen)(Hdips)2] (Hdips 3,5-diisopropylsalicylate) had
potent in vitro cytotoxicity it was inactive when tested on mice bearing tumour, suggesting that it is
destroyed by interaction with biofluids and is not stable enough to reach the tumour cells in vivo.
in vitro experiments revealed that metal complexes of 3,5,6,8- or 3,4,7,8-tetramethyl-l,10-
phen (metal Ni(II), Fe(II), Co(II), Cu(II), Zn(II), Cd(II), Mn(II), Ru(II)), the metal-free
hydrochlorides and quaternary salts of the bases were bactericidal to veterinary samples of
Erysipelothrix rhusiopathiae and Fusiformis nodosus.
35 Resistant variants of E. rhusiopathiae
were not produced by repeated subculture in the presence of [Cu(3,4,7,8-tetramethyl-l,10-
phen)2]X2 (X benzoate or acetate). Likewise, Staphylococcus aureus, Mycobacterium
tuberculosis, E. coli, Candida albicans and Trichophyton mentagrophytes develop little resistance
to this type of complex.3’36 On the basis of these experiments it was suggested that the complexes
could possibly be used to treat erysipelas in pigs, and may also be beneficial in the treatment of
other topical infection of bacteria, mycotic or even viral origin. Furthermore, the latter Cu(II)
complex was shown to be at least as effective as solutions of formalin and dioxyethyl laural
ammonium chloride in the treatment of foot-rot in sheep. While useful clinically as topical
antimicrobials, a selection of phenanthroline complexes, when administered parenterally, were
found to be chemptherapeutically ineffective against experimental infection of mice with S. aureus,
Streptococcus pneumoniae and M. tuberculosis. Also, the complexes did not decrease ulcer
growt-h rate in guinea-pigs infected with M. tuberculosis.
Extensive microbiological and pharmacological investigations with phenanthrolines and
related chelates3’36 led to clinical studies with the highly stable Ni(II) and Fe(II) complexes of
3,4,7,8-tetramethyl-l,10-phen. These complexes were known to have a wide spectrum of
antimicrobial actions and to produce negligible toxicity to skin, subcutaneous tissues and mucous
membranes.
36 Preliminary studies had shown that the complexes were effective in controlling
infections due to S. aureus, C. albicans and selected dermatophytes found in hospital casualty,
dermatology, ear, nose and throat and gynaecology departments and in surgical wards. The Ni(II)
complex was equally as effective as hexachlorophene, when used as an immediate preoperative
skin preparation, in decreasing the incidence of postoperative staphylococcal wound infection in
elective abdominal surgery. Further trials established that the same complex was again as effective
as hexachlorophene in the prophylaxis of staphylococcal infection in the newly born and also in
37 patients undergoing elective obstetric or gynaecological surgery. The complex was also
beneficial in controlling secondary infection in adolescents with acne vulgaris of long standing.
The Ni(II) and the Cu(iI) complexes provided rapid relief of symptons in patients with either
chronic monilial infection of the nail or trichomonal vaginitis, attributable to C. albicans and
Trichophyton vaginalis, respectively. Furthermore, no toxic manifestations were observed with
either substance.
Mn(II) complexes of 3,4,7,8-tetramethyl-l,10-phen were used topically to treat patients
suffering from a variety of skin conditions, many of whom had chronic dermatological infections
due to dermatophytes (e.g. Malassezia furfur, Trichophyton rubrum) or Candida species.
38 The
complexes produced a significant decrease in microbial infection in approximately 50% of cases,
with infection due to Gram-positive bacteria generally responding much more rapidly and readily
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to treatment than that due to Gram-negative bacteria. The complexes did not produce noteworthy
irritation or sensitization of the underlying dermatosis or dermatomycosis and, furthermore,
significant microbial resistance did not develop.
Materials and Methods
All chemicals were reagent grade and used without further purification. Reactions
involving silver salts we[e carried out in the dark. Infrared spectra were recorded as KBr discs in
the region 4000-400 cm- on a Nicolet Impact 400D FT-IR Spectrometer. The spectra of the metal
carboxylate complexe contained prQninent VasymOCO and VsymOCO stretching bands at ca. 1600
cm and ca. 1400 cm-, reslectively. Additional characteristic bands were exhibited by the 1,10-
phen ligand (ca. 855 cm- and ca. 743 cm ). Elemental analysis were carried out by the
Microanalytical Laboratory, National University of Ireland, Cork, Ireland. Biological studies were
carried out in the Labsystems iEMS reader MF.
[Mn(mal)l.H2Q. To a solution of malonic acid {HO2CCH2CO2H, malH2} (10.0 g, 96 mmol) in
ethanol (40 cm) was added Mn(CH3CO2)2.4H20 (2.6 g, 10.6 mmol). The resulting solution was
allowed to reflux for 0.5h. The resulting white solid which deposited was filtered off, washed with
water and ethanol, and then air-dried.
[Co(mal)]malH2.2H20, [Cu(mal)].H20 and [Zn(mal)]malH2.2HxO were made in a similar
manner to [Mn(mal)].H20 using Co(CH3CO2)2.4H20, [Cu2(CH3CO2)4(H20)2] and
Zn(CH3COz)2.2H20, respectively.
[N.i(mal)(HxO)z] and [Ag2(mal)] (1) were prepared from Ni(CH3COz)z.4H20 and Ag(CH3CO2) and
using water as the reaction solvent.
[Mn(l,10-phen)z(mal)].2xO (2). To a solution of 1,10-phenanthroline monohydrate (2.20 g, 11.1
mmol) in ethanol (40 cm ) was added [Mn(mal)].H20 (0.75 g, 2.1 mmol) and the yellow solution
was refluxed for 0.5 h. The precipitated yellow solid was filtered off, washed with water and
ethanol, and then air-dried.
[Co(l,10-phen)3]mal.H20 (3), [Cu(l,10-phen)2(mal)].2H20 (4), [Ni(1,10-phen)2(mal)].2H20
(5), [Zn(1,10-phen)2(mal)l.2H20 (6) and [Ag2(1,10-phen)3(mal)].2H20 (7) were prepared in a
similar manner to 2.
[Mn(l,10-phen)zl(CH3CO).4H,zO (8). To a solution of 1,10-phenanthroline hydrate (1.78 g,
8.98 mmol) in ethanol (40 cm) was added Mn(CH3CO2):.4HeO (1.0 g, 4.08 mmol) and the
resulting yellow solution was refluxed for h. The solution was then concentrated by rotary
evaporation to encourage precipitation of the yellow product. The solid was washed with a small
volume of water and ethanol, and then air-dried.
[Cu(l,10-phen)(CH3CO2)2l.H20 (9) and [Zn(1,10-phen)(CH3CO2)21.2H20 (10) were made in a
similar manner to 8 using [Cue(CH3CO2)4(HeO)2] and Zn(CH3COe)e.2HeO, respectively.
[Mn(l,10-phen)2Cl21 (11). To a solution of 1,10-phenanthroline hydrate (1.10 g, 5.55 mmol) in
ethanol (40 cm") was added MnC12.4HeO (0.50 g, 2.53 mmol) andthe resulting yellow solution
refluxed for h. Upon cooling the resulting yellow crystals which deposited were filtered off,
washed with a small volume of ethanol and water, and then air-dried.
[Cu(l,10-phen)Cl2].H20 (12) and [Zn(l,10-phen)Cl2].H20 (13) were made in a similar manner to
11 using CuCI:.2H20 and ZnC12, respectively.
[Mn(1,7-phen)2(CH3CO23)2 (14). To a solution of 1,7-phenanthroline (1,7-phen) (0.5 g, 2.8
mmol) in ethanol (40 cm was added Mn(CH3CO2)e.4H20 (0.15 g 0.61 mmol) and th resulting
yellow solution was refluxed for h The solution was then evaporated down to 5 cm by rotary
eva3Poration, and then acetone (20 cm was added. The resulting solution was then evaporated to 3
cm and diethyl ether (7 cm added. This solution was allowed to evaporate in air over a period of
24 h and the resulting brown crystals were filtered off, washed with diethyl ether and ethanol, and
then air-dried.
[Cu(l,7-phen)(CH3CO2)2].2H20 (15) and [Zn(1,7-phen)(CH3CO2)2].H20 (16) were made in a
similar manner to 14 using [Cue(CH3CO2)4(HeO)2] and Zn(CH3CO:)2.2HeO, respectively.
Satisfactory microanalysis were obtained for all complexes and complexes (1)-(16) were
water-soluble.
Anti-Candida susceptibility testing
C. albicans (one clinical isolate) was obtained from St. James’s Hospital, Dublin,
Ireland. The isolates were stored on Sabouraud dextrose agar (SDA) plates at 4 C. Solutions of
the water-soluble test omplexes 1-16 were prepared by dissolving the complex(0.02 g) in
distilled water (100 cm) to yield a stock solution with a concentration of 200g cm". Doubling
dilutions of this stock solution were made to yield a series of test solutions ranging in
concentration from 200 0.195 g cm3.
RPMI-1640 broth medium (Sigma R 7755) was used for the anti-Candida susceptibility
testing. The medium (1 dm) was supplemented with L-glutamine (0.3 g) and
morpholinepropanesulfonic acid (MOPS) (34.6 g) and was then adjustel to pH 7.0 using sterile
NaOH (0.2 M). The broth microdilution reference method was used7 Prior to testing, yeast
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cells were grown on Sabouraud dextrose agar (SDA) at 37 C for 24 h. Cell suspensions were
prepared in sterile phosphate buffered saline (5 cm) to a density of 0.5 McFarland standard. A
1:100 dilution of these cell suspensions were made in RPMI-1640 medium so that the cell
concentration of the final inoculum was 3.5 x 104 5.0 x 105 cells cm3. The prepared cell
suspension (90 tl) was dispensed into sterile microtitre test plates and to this was added the
complex test solutiqn (10 1)to yield working solutions of the test complexes of concentration 20
0.0195 tg cm-. Minimum inhibitory concentration (MIC) determination on selected
complexes was carried out for 24 h at 3"7 C with continuous shaking. Each complex was
assessed in triplicate and three independent experiments were performed. The resulting nine data
points were statistically analysed using ANOVA one-way analysis of variance followed by
Tukey’s family error rate.
Oxidative stress studies
Yeast cells were grown on SDA at 37 C for 24 h. Cell susoensions were then prepared
in sterile phosphate buffered saline (PBS, 5 cm3) to a density of 6.5 McFarland standard. A
1:100 dilution of these cell suspensions was made inn RPMI-164Q medium (30 cm3) to give a cell
concentration in the final inoculum of 3.5 x 10 5.0 x 10 cells cm. The prepared cell
suspension was dislgensed into sterile Erylenmeyer flasks and the flasks then incubated in a
shaking water bath for 24 h at 37 C with continuous shaking. Cell growth was assessed using an
improved Neubauer haemocytometer chamber.
Cells growing in the mid exponentialphase (9 h) were collected by centrjfugation (3,000
rpm for 10/nin), washed twice with sterile PBS and suspended in PBS (9 m). To this was
added cm of the stock complex solution (complex 4 or 6; 0.2 g in 100 cm of water) to yield
working solutions of the test complexes of concentration 200 gg cm. The cell suspension was
then incubated at 37 C for h with gentle shaking. Cells were collected by centrifugation
(3,Q00 rpm for 10 min), washed three times with PBS and then suspended in ice-cold PBS (5
Cell viability_ studies were conducted by diluting the cells 1,000-fold with sterile distilled
water. Serial dilutions were performed so that approximately 100 cells were plated onto
individual SDA plates. The plates were incubated at 37 C for 24 h and the number of colonies
counted. Cell viability is expressed as % cells surviving after treatment with drug compared with
an untreated control.
Spheroplasts were prepared as follows. Glass beads were added to test and control cell
suspensions and the cells disrupted using a whirlimixer (30 cycles each of 2 min duration). In
between cycles cells were placed on ice. Cell wall removal was observed by light microscopy.
The spheroplasts were separated from the glass beads by aspiration and collected by
centrifqgation (3,000 rpm for 15 min). The resulting spheroplast pellet was resuspended in PBS
(10 cm) and samples of this were used separately for proten estrnation, lipid peroxidation and
glutathione assays.
Protein estimation on the spheroplasts was carried out using the Protein Assay Kit,
Sigma P 5656.
Lipid peroxidation. To ascertain if there were differences in lipid peroxidation in the
absence and in the presence of a metal complex the formation of lipid peroxiqlCs was indirectly
determined spectrophotometrically by a modification of the published method?" Malonaldehyde
(MDA) is a secondary product of lipid peroxidation. Thiobarbituric acid reacts with linoleic acid
hydroperoxide (a product of lipid peroxidation) in a heated reaction to form MDA and other
compounds. Since MDA is not the only product ofperoxidation the assay is not a direct
measurem_ent of MDA, although this is used as a standard. A pink colour is formed by this
reaction (, 540 nm) and an increased absorbance value is indicative of more extensive lipid
peroxidation and oxidative damage.
The reaction mixture comprised the spherollast suspension (0.2 cm3, 220 gg protein),
q_ta ueous sodium dodecyl sulphate (8.1% w/v, 0.2 cm"), aqueous acetic acid (20A v/v, adj’usted, to
pH 3.5 with NaOH, 1.5 cmJ), .aqueous 2-thiobarbituric acid (0.8% w/v, 1.5 cm ). The mxture
was finally made up to 4 cm with deionised water and then heated at 95 C for h. After
cooling to room temperature the mixture was filtered (0.45 tm membrane filter) and its
absorbance measured.
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Glutathione assay. Total gluthathione {reduced glutathione (GSH) plus o4,}idised glutathione (GSSG)} was determined using, a minor modification of the published method. Prior
to testing the spheroplast suspension (5 cm) was centrifuged and the resulting pellet was quickly
mixed with 5-sulphosalicylic acid (10% w/v, 5 cm3). T_he sample was centrifuged and the
supernatant retained. To a 7"eaction mixture comprising [5-nicotinamide adenine di-nucleotide
phosphate (reduced form, NADPH, 0.3 mM, 700 1), 5,5’-dithio-bis(2-nitrobenzoic acid) (DTNB)
(6.0 mM, 100 gl). and triethanolamine/’20 1) was added the above supematant (200 gl) and the
mixture then eqmlibrated to 37 C. To the solution was added glutathione reductase (50 units cm-,
10 1) and total glutathione content (GSH + GSSG) was estimated spectrophotometrically (_ 412
nm) by comparison to the rate ofreduction with known amounts ofDTNB.
GSH content alone was determined using the same procedure as that described above for
total glutathione with the exception that 2-vinyl-pyridine (10 gl) was added prior to the addition
of the glutathione reductase.
Results and Discussion
At a concentration of 20 gg cm
3 malonic acid has previously been reported to have
negligible inhibitory effect on C. albicans.
23 In addition, the present study has shown that the
simple metal malonates (metal Mn(II), Co(II), Ni(II), Cu(II), Zn(II)) and Ni(CH3CO2)2.4H20
also have negligible activity against the yeast.
MIC values were determined for metal-free 1,10-phen, Ag(CH3CO2), [Ag2(mal)] (1) and
the metal-l,10-phen complexes 2-7 on the growth of C. albicans (Table 1). Values for metal-
free 1,10-phen, Ag(CH3CO2), and the Mn(II), Cu(II) and Ag(I) 1,10-phen complexes (2, 4 and 7,
respectively) all fell within the range 1.25-2.5 gg cm. The fact that the activity of metal-free
1,10-phen and its Cu(II) complex 4 are quite similar contrasts somewhat with the observations of
Seydel et a143 who found that addition of Cu(II) ions to derivatised 1,10-phenanthroline ligands
led to a decrease in the anti-Candida activities of the metal-flee ligands.
MIC values inc,reased progressively for the Zn(II) 1,10-phen complex 6 and the Ag(I)
malonate 1 (>5 g cm), and substantially higher MIC values (>20 gg cm) were found for the
Co(II) and Ni(II) 1,10-phen complexes (3 and 5, respectively). Results for the three Ag(I)
complexes indicate that it is the Ag
+ ion itself that is the active species and that neither the
presence of 1,10-phen or the nature of the carboxylate anion are contributory factors in
determining activity.
Table 1. MIC of 1,10-phen, metal-l,10-phen complexes and selected starting materials on C.
albicans.
Complex g cm
-3
1,10-phen
[Mn(1,10-phen)2](mal)e.2H20 (2)
[Co(l,10-phen)3](mal)2.H20 (3)
[Cu( 1,10-phen)(mal)2].2H20 (4)
[Ni(1,10-phen)z](mal)2.2H20 (5)
[Zn(1,10-phen)(mal)2].2H20 (6)
Ag(CH3CO2)
[Ag(mal)] (1)
[Ag(1,10-phen)3(mal)].2H20 (7)
1.25-2.5
1.25-2.5
>20
1.25-2.5
>20
>5
1.25-2.5
>5
1.25-2.5
Compounds were tested within a concentration range of 20 0.0195 gg cm
3 of aqueous RPMI
medium.
It is significant that Ag(CH3CO2) is the only complex not to contain 1,10-phenanthroline
but to exhibit activity similar to that of metal-free 1,10-phen and other metal complexes containing
the 1,10-phen ligand. Previous studies have shown that the MIC values of simple metal acetates
(metal Mn(II), Cu(II) and Co(II))
44 is >20 gg cm-3. In addition, by studying the anti-Candida
activity of a series of complexes (concentration 20 gg cm"3) of general formula [M(1,10-
phen)n]Xy (M Mn(II), Cu(II), Zn(II); X malonate, acetate, chloride) it was established that the
nature of the counter anion X does not influence the inhibitory effect (Table 2).
In contrast to the performance of the highly active metal-free 1,10-phen ligand metal-free
1,7- and 4,7-phenanthroline (Fig. 2) were both inactive and, furthermore, Cu(II), Mn(II) and Zn(II)
complexs of 1,7-phen displayed only marginal activity (Table 2).
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Figure 2. (a) 1,7-Phenanthroline (1,7-phen); (b) 4,7-phenanthroline (4,7-phen).
Although all of the phenanthroline isomers can coordinate to metal centres 1,10-phen is the only
ligand capable of actually chelating the metal and forming an extremely stable metal-phen entity in
solution. These observations would appear to substantiate the hypothesis that the bioactivity of
N,N-chelating bases is attributed to their ability to sequester specific transition metals and that it is
the resulting metal chelate complex that are the active species.
Table 2. Anti-Candida activity of [M(1,10-phen)n]X (M Mn(II), Cu(II), Zn(II); X
malonate, acetate, chloride), [M(1,7-phen)n]acetate (M Mn(II), Cu(II), Zn(II) and metal free
phen ligands.
Complex % Cell
growth
[Mn(1,10-phen)2](mal)2.2H20 (2)
[Cu(1,10-phen)(mal)2].2H20 (4)
[Zn(1,10-phen)(mal)2].2H20 (6)
[Mn(1,10-phen)2](CH3CO2)z.4H20 (8)
Cu(1,10.-phen)(CHaCO2)2].H20 (9)
[Zn(1,10-phen)(CHaCOE)E].2H20 (10)
[Mn(1,10-phen)2C12] (11)
[Cu(1,10-phen)C1E].H20 (12)
[Zn(1,10-phen)C1E].H20 (13)
[Mn(1,7-phen)E(CHaCO2)2] (14)
[Cu(1,7-phen)(CHaCOE)E].2H20 (15)
[Zn(1,7-phen)(CHaCOE)E].H20 (16)
1,7-phen
4,7-phen
1,10-phen
0
0
89+9
2+0.1
8+2
80+9
3 + 0.001
5+2
90+4
83+5
89+9
97+ 12
99+9
93+13
0
Complexes were tested at a concentration of 20 l.tg cm
"3 of aqueous RPMI medium. Yeast cells
were grown for 24 h at 37 C. Results are presented as % cell growth and the effectiveness of the
compounds are compared to the growth of the control (no added complex).
The kinetic growth profile of the yeast when it was exposed to sub-inhibitory concentration
of [Mn(1,10-phen)2(mal)].2H20 (2) (0.156 l.tg cm"3) is shown in Fig. 3. Control cells and cells
treated with complex 2 enter the early exponential phase at the same time (4 h). However, after
this stage growth of the Mn-treated cells is significantly reduced (doubling time approximately 600
min) when compared to the control (120 min). This result suggests that the cells have to
metabolically active before the administered metal complexes take effect.
The MIC studies revealed two distinct groups of complexes exhibiting extremes of growth
inhibition. The Mn(II), Cu(II) and Ag(I) complexes (2, 4 and 7, respectively) were highly toxic,
whereas the Co(II), Ni(II) and Zn(II) complexes (3, 5 and 6, respectively) were ineffective. On the
basis of these results a representative complex was selected from each group ([Cu(1,10-
phen)2(mal)].2H20 (4) and [Zn(1,10-phen)2(mal)].2H20 (6)) for oxidative stress studies. Cells
were grown to mid-exponential phase and separate samples of these cells (each batch containing
approximately 2 x 10 cells) were treated with 4 and 6 (200 _g cm-3) for h at 37 C. The viability
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of cells treated with 4 (9 _+ 2%) and 6 (80 +_ 9%) highlights the pronounced toxicity of the cop.per
z15,46 complex (Table 3). GSH xs known to be an xmportant antloxdant molecule in yeast cells.
GSH:GSSG ratios determined for the control (17:1), [Zn(1,10-phen)_(mal)].2HaO (6) (22:1) and
[Cu(1,10-phen)a(mal)].2HaO (4) (5:1) clearly demonstrates that the copper complex induces
significant cellular oxidative stress. Furthermore, whereas cells treated with the Zn(II) complex 6
showed no elevation in the level of lipid peroxides (compared to the control) those exposed to the
Cu(II) complex 4 had a 7-fold increase. In relation to this result it is known that, as well as
targeting ergosterol in the fungal cell membrane and causing pore formation, the polvene antifungal
amphotericin B also promotes peroxidation of membrane lipids in Candida cells.
47 C. albicans
when exposed to a low dose ofgamma-radiation is also known to undergo lipid peroxidation.
4
Figure 3. Kinetic growth curve of control cells and cells treated with
Phen)a](mal)a.4HaO (2).
[Mn(1,10-
+ Contrd
--,2
0 4 8 12 16 20 24
Time (h)
The kinetics of a sub-inhibitory concentration (0.156 Bg cm3) of complex 2 was followed
spectrophotometrically (abs. 540 nm). The cells were grown in RPMI aqueous medium and
readings were taken every 4 h over a 24 h period. The results presented are a representative of a
total of three independent experiments.
Table 3. Cell viability, protein estimation, lipid peroxide level and GSH:GSSG.
Viability Protein Lipid peroxides
b GSH:GSSG
(%) (Bg/ml)
Control 100 1173 + 12 1"1 17"
Complex (4) 9 + 2 1196 + 22 7"1 5"1
Complex (6) 80 + 9 1104 + 29 1"1 22"1
Viability is expressed_ as the % cellso ..survivin-(mean _.+se (n 9)) after treatment with drug
comparedto an untreated control. Lipid peroxide formation was measured at an absorbance at
540 nm. The level of lipid peroxidati-on was obtained by comparing the absorption of the test
drugs compared to the absotion of the control. The results are expressed as the mean of three
independent experiments. The ratio of reduced glutathione (GSH) and oxidized glutathione
(GSSG) was calculated from the absorbance at 412 nm using the rate of reduction of DTNB as
an external standard, and expressed as mean of three independent experiments.
In conclusion, it seems possible that the heightened anti-Candida activity of the bis(1,10-phen)
Mn(II) and Cu(II) complexes, in contrast to that of the Ni(II) and Zn(II) analogous, may be
attributed to the fact that the metal centers in the former can have variable oxidation states and
are thus potential Fenton reagents. Indeed, the ability of redox-active phenanthroline and
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bipyridine metal complexes to catalyze the oxidative modification of proteins, nucleic acids and
lipids has previously been attributed to the interactions of the substrate with H202 and the metal;
i.e. to simple Fenton-type chemistry.
48 The inability of the metal centers in the present Ni(II) and
Zn(II) 1,10-phen complexes to redox-cycle would render them incapable of assuming the role of
a Fenton reagent. Although the tris(1,10-phen)Co(II) complex (3) would be expected to have a
readily accessible and reversible Co(III) oxidation state the metal is coordinatively saturated with
respect to 1,10-phen and the complex is thus likely to be extremely kinetically inert.
The consistently high activity displayed by the three different Ag(I) complexes,
Ag(CH3CO2), [Ag2(mal)] (1) and [Ag2(1,10-phen)3(mal)].2H20 (7), indicates that in these instances
it is the metal center and not the ligands that dictates complex performance. As Ag(I) is renowned
for its ability to bind strongly to S-donor ligands
25 it is likely that the silver complexes will have a
high affinity for the sulphur atoms of thiol proteins and may, ultimately, induce protein
inactivation.
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